Letter from the Editor: Cost-effectiveness of tuberculosis screening in patients already on biologic therapy.
Letter from the Editor: Cost-effectiveness of tuberculosis screening in patients already on biologic therapy. J Am Acad Dermatol. 2022 10; 87(4):747-748.